Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Comparison of Bypassing Agents in Patients on Emicizumab Using Global Hemostasis Assays

Hande Kizilocak, Elizabeth Marquez-Casas, BS, Jemily Malvar, MS, Roxana Carmona, MD, Guy Young, MD

Blood (2019) 134 (Supplement_1): 904.

https://doi.org/10.1182/blood-2019-132050

Published: 2019

Journal Articles

Unexpected Toxicities When Nivolumab Was Given after Allogeneic Stem Cell Transplantation

Amy Wang, MD MPH, Justin Kline, MD, Wendy Stock, MD, Satyajit Kosuri, MD, Andrew S. Artz, MD, Richard A. Larson, MD, Peter A. Riedell, MD, Michael R. Bishop, MD, Hongtao Liu, MD PhD

Blood (2019) 134 (Supplement_1): 1956.

https://doi.org/10.1182/blood-2019-123887

Published: 2019

Journal Articles

Prevention and Management of Daratumumab Mediated Infusion Related Hypersensitivity Reactions Pre-and Post-Implementation of Rapid Infusion Protocol

My L Nguyen, PharmD, Catherine Burdalski, PharmD, BCOP, Syed Abbas Ali, MD, Lindsay Kohler, BS, PharmD Candidate, Steven Gilmore, PharmD, BCOP

Blood (2019) 134 (Supplement_1): 5811.

https://doi.org/10.1182/blood-2019-125391

Published: 2019

Journal Articles

Key Histopathology Features of Cutaneous Acute Graft-Versus-Host Disease Can be Detected Noninvasively

Inga Saknite, PhD, Melissa Gill, MD, Alessi-Fox Christi, MS, Jeffrey P Zwerner, MD PhD, Julia S Lehman, MD, Michi M Shinohara, MD, Roberto A Novoa, MD, Michael T Byrne, DO, Madan Jagasia, MBBS, MS, MMHC, Salvador Gonzalez, MD PhD, Marco Ardigo, MD PhD, Eric R. Tkaczyk, MD PhD

Blood (2019) 134 (Supplement_1): 3278.

https://doi.org/10.1182/blood-2019-131317

Published: 2019

Journal Articles

An Update on Safety and Preliminary Efficacy of Highly Specific Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Combination with PD-1 Inhibitor Tislelizumab in Patients with Previously Treated B-Cell Lymphoid Malignancies

Constantine S. Tam, MBBS, MD, Gavin Cull, MB, BS, FRACP, FRCPA, Stephen Opat, Gareth P Gregory, MBBS (Hons), PhD FRACP, FRCPA, Aichun Liu, MD, Anna M. Johnston, Weili Zhao, MD PhD, Fernando Roncolato, BMed, FRACP, FRCPA, Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, H. Miles Prince, MBBS (Hons), MD FRACP, FRCPA, AFRCMA, MACD, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, Wenyu Li, MD PhD, Ted Shih, PharmD, Xiaoping Zhang, MD MS, Ken Wu, PhD, Yuan Liu, Jane Huang, MD, Judith Trotman, MBChB, FRACP, FRCPA

Blood (2019) 134 (Supplement_1): 1594.

https://doi.org/10.1182/blood-2019-125485

Published: 2019

Journal Articles

Risk of Subsequent Thrombosis in Patients with Isolated Heparin-Induced Thrombocytopenia

Heather R Wolfe, MD, Yu-Min Shen, MD

Blood (2018) 132 (Supplement 1): 3566.

https://doi.org/10.1182/blood-2018-99-117629

Published: 2018

Journal Articles

Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

Mustafa Saudi, MD

Blood (2018) 132 (Supplement 1): 5035.

https://doi.org/10.1182/blood-2018-99-117765

Published: 2018

Journal Articles

Rash in Patients after T-Cell-Depleted Peripheral Blood Stem Cell Transplantation: Eosinophilia and Pruritus Do Not Distinguish Acute Graft-Versus-Host Disease from Drug Rash

Skylar A Klager, MS, Sean M Devlin, PhD, Margaret Hannum, MS, Ann A. Jakubowski, MD PhD, Alina Markova, MD

Blood (2018) 132 (Supplement 1): 4570.

https://doi.org/10.1182/blood-2018-99-110307

Published: 2018

Journal Articles

A Novel Device Suitable for Home Monitoring of White Blood Cell and Neutrophil Counts

David C Dale, MD, Merideth L. Kelley, MSc, Myriam Navarro-De La Vega, Dhruv Parthasarathy, Deepika Bodapati, Louis Virey, MSc, Steve Moffatt, BSc, Tanay Tandon

Blood (2018) 132 (Supplement 1): 1103.

https://doi.org/10.1182/blood-2018-99-112647

Published: 2018

Journal Articles

A Single Institution's Adherence to Heparin-Induced Thrombocytopenia and Thrombosis Testing Guidelines

Kristine Gade, MD BS, Jack Melson, MD, Alex Jepsen, MD, Surabhi Palkimas, PharmD, Bethany Horton, PhD, Hillary S. Maitland, MD MS

Blood (2018) 132 (Supplement 1): 4720.

https://doi.org/10.1182/blood-2018-99-117132

Published: 2018

Journal Articles

Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

Lihua Budde, MD PhD, Joo Y Song, MD, Young Kim, MD, Suzette Blanchard, PhD, Jamie Wagner, BS, Anthony S. Stein, MD, Lihong Weng, MD, Marissa Del Real, PhD, Rochelle Hernandez, Emanuela Marcucci, Jennifer K Shepphird, PhD, Xiuli Wang, PhD, Brent Wood, MDPhD, Guido Marcucci, MD, Christine E Brown, PhD, Stephen J. Forman, MD FACP

Blood (2017) 130 (Supplement 1): 811.

https://doi.org/10.1182/blood.V130.Suppl_1.811.811

Published: 2017

Journal Articles

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Seung Lee, bs, Coby Palmares, Niko Koutsoukos, J. Brice Weinberg, MD, Trisa Palmares, MD, Alice Song, MD, Harold Song, MD, Sheila Benedicto, bs, Michael Song, bs, Vu Phan, MD, Julia Song, MD

Blood (2016) 128 (22): 5500.

https://doi.org/10.1182/blood.V128.22.5500.5500

Published: 2016

Journal Articles

Long-Term Safety Experience with Bendamustine for Injection in a Real-World Setting

Peter Martin, MD, Paul Barr, MD, Brad S. Kahl, MD, Ashutosh Pathak

Blood (2016) 128 (22): 5591.

https://doi.org/10.1182/blood.V128.22.5591.5591

Published: 2016

Journal Articles

Haploidentical Transplantation for DOCK8 Deficiency

Nirali N Shah, MD, Alexandra F Freeman, MD, Mark Parta, MD, Helen Su, MD PhD, Gulbu Uzel, MD, Juan C. Gea-Banacloche, MD, Steven M. Holland, MD, Dennis D. Hickstein, MD

Blood (2015) 126 (23): 2229.

https://doi.org/10.1182/blood.V126.23.2229.2229

Published: 2015

Journal Articles

Ibrutinib-Associated Rash: Single-Center Experience of Clinicopathologic Features and Management

David J Iberri, MD, Bernice Kwong, MD, Laurel Stevens, MD, Steven E Coutre, MD, Jinah Kim, MD PhD, Jean Sabile, BS, Ranjana H Advani, MD

Blood (2015) 126 (23): 4860.

https://doi.org/10.1182/blood.V126.23.4860.4860

Published: 2015

Journal Articles

Safety and Efficacy of Rapid (one hour) Single Intravenous Dose Low Molecular Weight Iron Dextran for Treatment of Oral Iron Intolerant Maternal Iron Deficient Anemia

Michael Auerbach, MD, Lilee Wong, MD, Jessica McClintock, MD, Steven Lenowitz, MD, Nicola London, MD, Sarah Auerbach, BBA, Samuel Smith, MD

Blood (2015) 126 (23): 3356.

https://doi.org/10.1182/blood.V126.23.3356.3356

Published: 2015

Journal Articles

Identification and Clinical Characterization of Children with Benign Neutropenia

Michael Vincent Ortiz, MD, Emily R. Meier, MD, Griffin P. Rodgers, MD, Matthew Hsieh, MD

Blood (2014) 124 (21): 4956.

https://doi.org/10.1182/blood.V124.21.4956.4956

Published: 2014

Journal Articles

Serum Cytokine Profile in Patients with Septic Shock/Severe Sepsis and Thrombocytopenia

Panagiotis Tsirigotis, MD, Konstantinos Gkirkas, MD, Spiros Chondropoulos, MD, Ioannis Papassotiriou, PhD, Anastasia Bartzeliotou, PhD, Christina Economopoulou, MD, Maria Atta, MD, Nikolaos Papanikolaou, MD, Dikea-Eleni Ioannidou, MD, Diamantina Vasilatou, MD, Sotirios G Papageorgiou, MD, Maria Stamouli, MD, Vassiliki Pappa, MD, Ioanna Dimopoulou, MD

Blood (2014) 124 (21): 1426.

https://doi.org/10.1182/blood.V124.21.1426.1426

Published: 2014

Journal Articles

Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test

Ishac Nazi, PhD, Donald M Arnold, MD, James W Smith, BSc, MT, Theodore E. Warkentin, MD, Jane C Moore, BSc, MT, Peter Horsewood, PhD, John G. Kelton, MD FRCPC

Blood (2014) 124 (21): 2757.

https://doi.org/10.1182/blood.V124.21.2757.2757

Published: 2014

Journal Articles

Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis – a Phase II Study

Ran Reshef, MD, James K. Mangan, MDPhD, Selina M. Luger, MD, Alison Wakoff Loren, MDMS, Elizabeth O. Hexner, MD, Noelle V. Frey, MDMS, Edward A. Stadtmauer, MD, Robin E. Blauser, BSN RN, Lee P. Richman, BA, Austin P. Huffman, BA, Alex Ganetsky, PharmD, Edward P. Acosta, PharmD, James A. Hoxie, MD, Rosemarie Mick, MS, Robert H. Vonderheide, MDDPhil, David L. Porter, MD

Blood (2014) 124 (21): 2491.

https://doi.org/10.1182/blood.V124.21.2491.2491

Published: 2014

NARROW

Comparison of Bypassing Agents in Patients on Emicizumab Using Global Hemostasis Assays

Unexpected Toxicities When Nivolumab Was Given after Allogeneic Stem Cell Transplantation

Prevention and Management of Daratumumab Mediated Infusion Related Hypersensitivity Reactions Pre-and Post-Implementation of Rapid Infusion Protocol

Key Histopathology Features of Cutaneous Acute Graft-Versus-Host Disease Can be Detected Noninvasively

An Update on Safety and Preliminary Efficacy of Highly Specific Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Combination with PD-1 Inhibitor Tislelizumab in Patients with Previously Treated B-Cell Lymphoid Malignancies

Risk of Subsequent Thrombosis in Patients with Isolated Heparin-Induced Thrombocytopenia

Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

Rash in Patients after T-Cell-Depleted Peripheral Blood Stem Cell Transplantation: Eosinophilia and Pruritus Do Not Distinguish Acute Graft-Versus-Host Disease from Drug Rash

A Novel Device Suitable for Home Monitoring of White Blood Cell and Neutrophil Counts

A Single Institution's Adherence to Heparin-Induced Thrombocytopenia and Thrombosis Testing Guidelines

Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Long-Term Safety Experience with Bendamustine for Injection in a Real-World Setting

Haploidentical Transplantation for DOCK8 Deficiency

Ibrutinib-Associated Rash: Single-Center Experience of Clinicopathologic Features and Management

Safety and Efficacy of Rapid (one hour) Single Intravenous Dose Low Molecular Weight Iron Dextran for Treatment of Oral Iron Intolerant Maternal Iron Deficient Anemia

Identification and Clinical Characterization of Children with Benign Neutropenia

Serum Cytokine Profile in Patients with Septic Shock/Severe Sepsis and Thrombocytopenia

Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test

Extended CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis – a Phase II Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only